Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 13:15:1505082.
doi: 10.3389/fendo.2024.1505082. eCollection 2024.

Association of circulating adiponectin and leptin levels with the risk of diabetic peripheral neuropathy

Affiliations

Association of circulating adiponectin and leptin levels with the risk of diabetic peripheral neuropathy

Zongcun Chen et al. Front Endocrinol (Lausanne). .

Abstract

Background: Adipokines have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and related complications due to their roles in metabolic regulation and inflammation. However, the relationship between these adipokines and diabetic peripheral neuropathy (DPN) remains unclear.

Methods: A case-control study was performed with 198 patients with DPN and 205 T2DM patients without DPN from the Endocrinology Department at the Second Affiliated Hospital of Hainan Medical University. Circulating adiponectin and leptin levels were quantified via enzyme-linked immunosorbent assays. Logistic regression models, adjusting for age, sex, BMI, smoking status, and diabetes duration, were applied to evaluate the associations between adiponectin and leptin levels and DPN risk.

Results: DPN patients exhibited lower adiponectin (P=0.001) and higher leptin (P=0.007) levels than diabetic controls. Confounders-adjusted analyses revealed that higher adiponectin levels correlated with reduced DPN risk (OR, tertile 3 vs. tertile 1: 0.52; 95% CI: 0.30-0.90), whereas elevated leptin levels were linked to increased DPN risk (OR, tertile 3 vs. tertile 1: 1.91; 95% CI: 1.10-3.32). Stratified analyses confirmed consistent findings across subgroups without statistically significant interactions.

Conclusions: Circulating adiponectin and leptin levels correlate with DPN risk in diabetic patients, suggesting their potential as biomarkers for high-risk DPN identification and guiding targeted prevention and management.

Keywords: adiponectin; association; case-control study; diabetic peripheral neuropathy; leptin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Levels of adiponectin and leptin among DPN patients and diabetic controls. DPN, diabetic peripheral neuropathy. Levels between groups were compared using a Mann-Whitney U test.

Similar articles

References

    1. Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, et al. . Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes endocrinology. (2019) 7:938–48. doi: 10.1016/S2213-8587(19)30081-6 - DOI - PubMed
    1. Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, et al. . Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurology. (2022) 21:922–36. doi: 10.1016/S1474-4422(22)00188-0 - DOI - PMC - PubMed
    1. Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, et al. . Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options. Int J Mol Sci. (2023) 24:3554. doi: 10.3390/ijms24043554 - DOI - PMC - PubMed
    1. Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and management strategies for diabetic neuropathy. Life (Basel). (2022) 12:1185. doi: 10.3390/life12081185 - DOI - PMC - PubMed
    1. Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front endocrinology. (2013) 4:71. doi: 10.3389/fendo.2013.00071 - DOI - PMC - PubMed

LinkOut - more resources